Eric M. Dube
Chief Executive Officer at Travere Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Travere Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Travere Therapeutics Inc. May 19, 202699.1%
-
Travere Therapeutics Inc. May 15, 202599.4%
-
Travere Therapeutics Inc. May 8, 202496.2%
-
Travere Therapeutics Inc. May 17, 202395.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 15, 2026 | Travere Therapeutics Inc. | Option exercise | +43,735 | $26.88 | $1,175,597 |
| Oct 15, 2026 | Travere Therapeutics Inc. | Option exercise | +200,000 | $8.93 | $1,786,000 |
| Oct 15, 2026 | Travere Therapeutics Inc. | Open-market sale | −128,065 | $52.97 | $6,783,244 |
| Oct 15, 2026 | Travere Therapeutics Inc. | Open-market sale | −37,270 | $54.20 | $2,020,023 |
| Oct 15, 2026 | Travere Therapeutics Inc. | Open-market sale | −78,400 | $55.02 | $4,313,403 |
| Sep 17, 2026 | Travere Therapeutics Inc. | Option exercise | +108,493 | $23.34 | $2,532,227 |
| Sep 17, 2026 | Travere Therapeutics Inc. | Open-market sale | −101,691 | $64.59 | $6,568,222 |
| Sep 17, 2026 | Travere Therapeutics Inc. | Open-market sale | −6,802 | $64.95 | $441,790 |
| Sep 16, 2026 | Travere Therapeutics Inc. | Option exercise | +195,841 | $23.34 | $4,570,929 |
| Sep 16, 2026 | Travere Therapeutics Inc. | Open-market sale | −99,716 | $63.26 | $6,308,034 |
| Sep 16, 2026 | Travere Therapeutics Inc. | Open-market sale | −96,125 | $63.64 | $6,117,395 |
| Sep 15, 2026 | Travere Therapeutics Inc. | Option exercise | +95,666 | $23.34 | $2,232,844 |
| Sep 15, 2026 | Travere Therapeutics Inc. | Open-market sale | −63,498 | $61.99 | $3,936,241 |
| Sep 15, 2026 | Travere Therapeutics Inc. | Open-market sale | −28,796 | $62.66 | $1,804,357 |
| Sep 15, 2026 | Travere Therapeutics Inc. | Open-market sale | −3,102 | $63.64 | $197,411 |
Questions about Eric M. Dube
What boards is Eric M. Dube on?
Eric M. Dube sits on the boards of OnKure Therapeutics Inc. and Travere Therapeutics Inc.
What company is Eric M. Dube the CEO of?
Eric M. Dube is Chief Executive Officer of Travere Therapeutics Inc.
How long has Eric M. Dube served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.